Evidence map›Paper›PMID 27272120›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2016

Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals.

D Delle Rose, P Pezzotti, E Fortunato, P Sordillo, S Gini, S Boros, M Meledandri, M T Gallo, G Prignano, R Caccese and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Associations Between Candida andMicroorganisms · 2025
    Article
  4. Article
  5. Article
  6. Droplet Digital PCR forAntibiotics (Basel, Switzerland) · 2024
    Article
  7. Review
  8. Rebound Inverts theAntibiotics (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Spotlight on New Antibiotics for the Treatment of Pneumonia.Clinical medicine insights. Circulatory, respiratory and pulmonary medicine · 2020
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

D Delle RoseClinical Infectious Diseases, Tor Vergata University Hospital, V. le Oxford 81, 00133, Rome, Italy. diego.dellerose82@gmail.com.
P PezzottiIstituto Superiore di Sanità, Rome, Italy.
E FortunatoClinical Infectious Diseases, Tor Vergata University Hospital, V. le Oxford 81, 00133, Rome, Italy.
P SordilloClinical Infectious Diseases, Tor Vergata University Hospital, V. le Oxford 81, 00133, Rome, Italy.
S GiniClinical Infectious Diseases, Tor Vergata University Hospital, V. le Oxford 81, 00133, Rome, Italy.
S BorosIstituto Superiore di Sanità, Rome, Italy.
M MeledandriS. Filippo Neri Hospital, Rome, Italy.
M T GalloSan Gallicano Dermatologic Institute, IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
G PrignanoSan Gallicano Dermatologic Institute, IRCCS, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.
R CacceseIntensive Care Unit, S. Giovanni Hospital, Rome, Italy.
M D'AmbrosioIntensive Care Unit, S. Giovanni Hospital, Rome, Italy.
G CitterioIntensive Care Unit, La Sapienza University, Rome, Italy.
M RoccoIntensive Care Unit, La Sapienza University, Rome, Italy.
F LeonardisIntensive Care Unit, Tor Vergata University Hospital, Rome, Italy.
S NatoliIntensive Care Unit, Tor Vergata University Hospital, Rome, Italy.
C FontanaClinical Microbiology Laboratories, Tor Vergata University Hospital, Rome, Italy.
M FavaroClinical Microbiology Laboratories, Tor Vergata University Hospital, Rome, Italy.
M G CelesteClinical Pharmacy, Tor Vergata University Hospital, Rome, Italy.
T FranciS. Andrea Hospital, Rome, Italy.
G P TestoreClinical Infectious Diseases, Tor Vergata University Hospital, V. le Oxford 81, 00133, Rome, Italy.
M AndreoniClinical Infectious Diseases, Tor Vergata University Hospital, V. le Oxford 81, 00133, Rome, Italy.
L SarmatiClinical Infectious Diseases, Tor Vergata University Hospital, V. le Oxford 81, 00133, Rome, Italy.
University of Rome Tor Vergata · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Superiore di Sanità · ITSapienza University of Rome · ITCTO Andrea Alesini · ITOspedale San Filippo Neri · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to assess the main clinical predictors and microbiological features of ventilator-associated pneumonia (VAP) in the Intensive Care Unit (ICU) environment. This work is a retrospective analysis over one year from September 2010 to September 2011. Patients' risk factors, causes of admission, comorbidities and respiratory specimens collected in six Italian ICUs were reviewed. Incidence and case fatality rate of VAP were evaluated. After stratification for VAP development, univariate and multivariate analyses were performed to assess the impact of patients' conditions on the onset of this infection. A total of 1,647 ICU patients (pts) were considered. Overall, 115 patients (6.9 %) experienced at least one episode of VAP. The incidence rate for VAP was 5.82/1,000 pts-days, with a case fatality rate of 44.3 %. Multivariate analysis showed that admission for neurological disorders (aIRR 4.12, CI 1.24-13.68, p = 0.02) and emergency referral to ICU from other hospitals (aIRR 2.11, CI 1.03-4.31, p = 0.04) were associated with higher risk of VAP, whereas a tendency to a higher risk of infection was detected for admission due to respiratory disease, cardiac disease, trauma and for having obesity or renal failure. A total of 372 microbiological isolates from respiratory specimens were collected in VAP patients. The most common species were Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa, showing high resistance rates to carbapenems. Neurological disorders and emergency referral at the admission into the ICU are significantly associated with the onset of VAP. A high incidence of multi-drug resistant Gram- species was detected in the respiratory specimens.

Indexed as

AdultAgedAged, 80 and overBacteriaCandidaFemaleHospitalsHumansIncidenceIntensive Care UnitsItalyMaleMiddle AgedMortalityPneumonia, Ventilator-AssociatedRetrospective Studies

Identifiers

PMID27272120
OpenAlexW2412895626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.